Font Size:
a
A
A
Keyword [Homologous Recombination Deficiency]
Result: 1 - 7 | Page: 1 of 1
1.
The Latest Progress Of Oral Targeted Drug—PAPRi In Epithelial Recurrent Ovarian Cancer
2.
Cancer-testis Oncogene MEIOB Sensitizes Triple-negative Breast Cancer To PARP1 Inhibitor By Inducing Homologous Recombination Deficiency
3.
Clinical Features And Prognostic Analysis Of Multiple Primary Malignant Tumors In Gynecology And The Value Of Homologous Recombination Repair-related Gene Detection In It
4.
Exploration Of Prognostic Factors In Triple-Negative Breast Cancer With High Risk Of Recurrence And Progression
5.
Clinicopathological Features And Prognosis Of Ovarian High-grade Serous Carcinoma With Homologous Recombination Deficiency
6.
Factors Related To PARP Inhibitors In Ovarian Cancermaintenance Therapy And Their Association With HRD Scores
7.
CDK4/6 Inhibitor Reverses Acquired Drug Resistance Of PARP Inhibitor In Ovarian Epithelial Carcinoma By Restoring Homologous Recombination Deficiency
<<First
<Prev Next>
Last>>
Jump to
